CA1178875A - Stabilization of coenzymes in aqueous solution - Google Patents
Stabilization of coenzymes in aqueous solutionInfo
- Publication number
- CA1178875A CA1178875A CA000366093A CA366093A CA1178875A CA 1178875 A CA1178875 A CA 1178875A CA 000366093 A CA000366093 A CA 000366093A CA 366093 A CA366093 A CA 366093A CA 1178875 A CA1178875 A CA 1178875A
- Authority
- CA
- Canada
- Prior art keywords
- coenzyme
- solution
- enzyme
- substrate
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000005515 coenzyme Substances 0.000 title claims abstract description 297
- 239000007864 aqueous solution Substances 0.000 title claims description 43
- 230000006641 stabilisation Effects 0.000 title description 9
- 238000011105 stabilization Methods 0.000 title description 9
- 239000000758 substrate Substances 0.000 claims abstract description 183
- 102000004190 Enzymes Human genes 0.000 claims abstract description 169
- 108090000790 Enzymes Proteins 0.000 claims abstract description 169
- 238000003556 assay Methods 0.000 claims abstract description 119
- 238000006243 chemical reaction Methods 0.000 claims abstract description 67
- 239000012084 conversion product Substances 0.000 claims abstract description 41
- 239000000470 constituent Substances 0.000 claims abstract description 39
- 230000001172 regenerating effect Effects 0.000 claims abstract description 12
- 239000000243 solution Substances 0.000 claims description 287
- 239000003153 chemical reaction reagent Substances 0.000 claims description 139
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 120
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 claims description 104
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 104
- 239000008103 glucose Substances 0.000 claims description 82
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 81
- 238000000034 method Methods 0.000 claims description 50
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 45
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 44
- 102000005548 Hexokinase Human genes 0.000 claims description 42
- 108700040460 Hexokinases Proteins 0.000 claims description 42
- 230000000694 effects Effects 0.000 claims description 34
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 claims description 30
- 108010046334 Urease Proteins 0.000 claims description 30
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 30
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 29
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 25
- XTWYTFMLZFPYCI-KQYNXXCUSA-N 5'-adenylphosphoric acid Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XTWYTFMLZFPYCI-KQYNXXCUSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 23
- 101000950981 Bacillus subtilis (strain 168) Catabolic NAD-specific glutamate dehydrogenase RocG Proteins 0.000 claims description 22
- 102000016901 Glutamate dehydrogenase Human genes 0.000 claims description 22
- 235000013772 propylene glycol Nutrition 0.000 claims description 22
- 108010082126 Alanine transaminase Proteins 0.000 claims description 21
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 20
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims description 19
- 229910001868 water Inorganic materials 0.000 claims description 18
- 108010010803 Gelatin Proteins 0.000 claims description 15
- 229920000159 gelatin Polymers 0.000 claims description 15
- 239000008273 gelatin Substances 0.000 claims description 15
- 235000019322 gelatine Nutrition 0.000 claims description 15
- 235000011852 gelatine desserts Nutrition 0.000 claims description 15
- 101710088194 Dehydrogenase Proteins 0.000 claims description 14
- 238000004166 bioassay Methods 0.000 claims description 13
- DRBBFCLWYRJSJZ-UHFFFAOYSA-N N-phosphocreatine Chemical compound OC(=O)CN(C)C(=N)NP(O)(O)=O DRBBFCLWYRJSJZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000006172 buffering agent Substances 0.000 claims description 12
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 claims description 12
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims description 12
- 150000002894 organic compounds Chemical class 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 11
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 11
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 11
- 230000015556 catabolic process Effects 0.000 claims description 10
- 238000006731 degradation reaction Methods 0.000 claims description 10
- 230000000087 stabilizing effect Effects 0.000 claims description 10
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 claims description 9
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 claims description 9
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 9
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 9
- 229960003767 alanine Drugs 0.000 claims description 9
- 239000000047 product Substances 0.000 claims description 9
- 229960005261 aspartic acid Drugs 0.000 claims description 8
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 7
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims description 7
- 239000007983 Tris buffer Substances 0.000 claims description 7
- 230000000593 degrading effect Effects 0.000 claims description 6
- 210000004369 blood Anatomy 0.000 claims description 5
- 239000008280 blood Substances 0.000 claims description 5
- 239000000872 buffer Substances 0.000 claims description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 5
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 claims description 4
- 108090000340 Transaminases Proteins 0.000 claims description 4
- 229960004308 acetylcysteine Drugs 0.000 claims description 4
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 claims description 4
- 235000011285 magnesium acetate Nutrition 0.000 claims description 4
- 239000011654 magnesium acetate Substances 0.000 claims description 4
- 229940069446 magnesium acetate Drugs 0.000 claims description 4
- 150000003626 triacylglycerols Chemical class 0.000 claims description 4
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 239000007795 chemical reaction product Substances 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 239000003960 organic solvent Substances 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- ZKHQWZAMYRWXGA-KQYNXXCUSA-N Adenosine triphosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-N 0.000 claims description 2
- KPGXRSRHYNQIFN-UHFFFAOYSA-N 2-oxoglutaric acid Chemical compound OC(=O)CCC(=O)C(O)=O KPGXRSRHYNQIFN-UHFFFAOYSA-N 0.000 claims 11
- 101000833181 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Glycerol dehydrogenase 1 Proteins 0.000 claims 8
- XTWYTFMLZFPYCI-UHFFFAOYSA-N Adenosine diphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(O)=O)C(O)C1O XTWYTFMLZFPYCI-UHFFFAOYSA-N 0.000 claims 1
- 102000014898 transaminase activity proteins Human genes 0.000 claims 1
- 229940088598 enzyme Drugs 0.000 description 97
- 229950006238 nadide Drugs 0.000 description 62
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 description 57
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 26
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 23
- 102000004420 Creatine Kinase Human genes 0.000 description 14
- 108010042126 Creatine kinase Proteins 0.000 description 14
- 238000002835 absorbance Methods 0.000 description 13
- 239000004202 carbamide Substances 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 10
- 238000004519 manufacturing process Methods 0.000 description 10
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 9
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- 229910021529 ammonia Inorganic materials 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- 230000008929 regeneration Effects 0.000 description 8
- 238000011069 regeneration method Methods 0.000 description 8
- 239000007857 degradation product Substances 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- NBSCHQHZLSJFNQ-GASJEMHNSA-N D-Glucose 6-phosphate Chemical compound OC1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H](O)[C@H]1O NBSCHQHZLSJFNQ-GASJEMHNSA-N 0.000 description 5
- VFRROHXSMXFLSN-UHFFFAOYSA-N Glc6P Natural products OP(=O)(O)OCC(O)C(O)C(O)C(O)C=O VFRROHXSMXFLSN-UHFFFAOYSA-N 0.000 description 5
- 239000007853 buffer solution Substances 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000003908 quality control method Methods 0.000 description 5
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 4
- 239000002274 desiccant Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 3
- 102000003929 Transaminases Human genes 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000005859 coupling reaction Methods 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229930195712 glutamate Natural products 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- 102100029242 Hexokinase-2 Human genes 0.000 description 2
- 101710198385 Hexokinase-2 Proteins 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000013256 coordination polymer Substances 0.000 description 2
- 229960003624 creatine Drugs 0.000 description 2
- 239000006046 creatine Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000006911 enzymatic reaction Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 description 2
- 229960003681 gluconolactone Drugs 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000011177 media preparation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 238000005375 photometry Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- HWKRAUXFMLQKLS-UHFFFAOYSA-N 2-oxidanylidenepropanoic acid Chemical compound CC(=O)C(O)=O.CC(=O)C(O)=O HWKRAUXFMLQKLS-UHFFFAOYSA-N 0.000 description 1
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 1
- 102100031126 6-phosphogluconolactonase Human genes 0.000 description 1
- 108010029731 6-phosphogluconolactonase Proteins 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 241000182988 Assa Species 0.000 description 1
- -1 BUN Proteins 0.000 description 1
- 101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241001644893 Entandrophragma utile Species 0.000 description 1
- 241000490229 Eucephalus Species 0.000 description 1
- 108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 1
- 102100029236 Hexokinase-3 Human genes 0.000 description 1
- 101710198398 Hexokinase-3 Proteins 0.000 description 1
- 101710198395 Hexokinase-4 Proteins 0.000 description 1
- 102100029237 Hexokinase-4 Human genes 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 229910019093 NaOCl Inorganic materials 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000000779 depleting effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 229940079919 digestives enzyme preparation Drugs 0.000 description 1
- MCWXGJITAZMZEV-UHFFFAOYSA-N dimethoate Chemical compound CNC(=O)CSP(=S)(OC)OC MCWXGJITAZMZEV-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 229940125532 enzyme inhibitor Drugs 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000003230 hygroscopic agent Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 229940049920 malate Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 239000006174 pH buffer Substances 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- OJTDGPLHRSZIAV-UHFFFAOYSA-N propane-1,2-diol Chemical compound CC(O)CO.CC(O)CO OJTDGPLHRSZIAV-UHFFFAOYSA-N 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/58—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving urea or urease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/008—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions for determining co-enzymes or co-factors, e.g. NAD, ATP
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/121,225 US4394449A (en) | 1980-02-13 | 1980-02-13 | Stabilization of coenzymes in aqueous solution |
| US121,225 | 1980-02-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1178875A true CA1178875A (en) | 1984-12-04 |
Family
ID=22395341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000366093A Expired CA1178875A (en) | 1980-02-13 | 1980-12-03 | Stabilization of coenzymes in aqueous solution |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4394449A (OSRAM) |
| EP (1) | EP0034213B1 (OSRAM) |
| JP (1) | JPS56124395A (OSRAM) |
| AT (1) | ATE10208T1 (OSRAM) |
| CA (1) | CA1178875A (OSRAM) |
| DE (1) | DE3069608D1 (OSRAM) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3044454C2 (de) * | 1980-11-26 | 1982-12-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stabilisierte Enzymzubereitung |
| US4578265A (en) * | 1981-08-13 | 1986-03-25 | Laclede Professional Products, Inc. | Di-enzymatic dentifrice |
| AU574646B2 (en) * | 1982-07-19 | 1988-07-14 | Cooperbiomedical Inc. | Enzyme assay method |
| DE3236388A1 (de) * | 1982-10-01 | 1984-04-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur selektiven herstellung reduzierter sauerstoffspezies und hierfuer geeignete reagentien |
| US4657854A (en) * | 1983-05-05 | 1987-04-14 | Ivan Endre Modrovich | Assay systems based on magnesium-responsive enzymes |
| US4622294A (en) * | 1985-02-08 | 1986-11-11 | Kung Viola T | Liposome immunoassay reagent and method |
| JPH0673475B2 (ja) * | 1985-04-26 | 1994-09-21 | オリエンタル酵母工業株式会社 | イソクエン酸脱水素酵素の反応停止法 |
| US5258286A (en) * | 1985-07-02 | 1993-11-02 | Oriental Yeast Co., Ltd. | Method of terminating isocitrate dehydrogenase reaction |
| EP0227073A3 (en) * | 1985-12-23 | 1989-03-22 | F. Hoffmann-La Roche Ag | Method of determining a co-enzyme |
| US4897346A (en) * | 1986-07-15 | 1990-01-30 | Beckman Instruments, Inc. | Stabilized liquid enzyme composition for glucose determination |
| US4940659A (en) * | 1987-02-20 | 1990-07-10 | Monoclonetics International, Inc. | Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome |
| US5384247A (en) * | 1987-04-10 | 1995-01-24 | Boehringer Mannheim, Gmbh | Determination of sodium ions in fluids |
| GB8710882D0 (en) * | 1987-05-08 | 1987-06-10 | Health Lab Service Board | Estimation of reduced pyridine nucleotides |
| EP0415188B1 (en) * | 1989-08-28 | 1996-03-20 | F. Hoffmann-La Roche Ag | Enzymatic method for determining analyte concentrations |
| EP0463755A1 (en) * | 1990-06-27 | 1992-01-02 | INSTRUMENTATION LABORATORY S.p.A. | Stable aqueous NADH reagent and kit |
| US5116728A (en) * | 1990-07-20 | 1992-05-26 | Em Diagnostic Systems, Incorporated | Reagents for co2 detection |
| CA2111168A1 (en) * | 1992-12-21 | 1994-06-22 | Shing F. Kwan | Stable single liquid reagent for the determination of carbon dioxide in serum |
| AU682882B2 (en) * | 1993-09-17 | 1997-10-23 | Thermo Trace Ltd. | Reagent |
| EP0719345B1 (en) * | 1993-09-17 | 2000-09-27 | Trace Scientific Limited | Reagent for enzymatic determination of serum bicarbonate levels |
| AUPN200695A0 (en) * | 1995-03-28 | 1995-04-27 | Trace Scientific Pty Ltd | Transaminase reagent |
| AU710552B2 (en) * | 1995-03-28 | 1999-09-23 | Thermo Trace Ltd. | Reagent stabilized using coenzyme reduction system |
| ES2306453T3 (es) * | 1995-12-27 | 2008-11-01 | Asahi Kasei Pharma Corporation | Metodo para ensayar una muestra biologica. |
| JP3674015B2 (ja) * | 1996-10-02 | 2005-07-20 | 日東紡績株式会社 | 尿素窒素の測定方法およびその測定用キット |
| US5801006A (en) * | 1997-02-04 | 1998-09-01 | Specialty Assays, Inc. | Use of NADPH and NADH analogs in the measurement of enzyme activities and metabolites |
| US6380380B1 (en) | 1999-01-04 | 2002-04-30 | Specialty Assays, Inc. | Use of nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucliotide phosphate (NADP) analogs to measure enzyme activities metabolites and substrates |
| EP1425585A2 (en) * | 2001-09-11 | 2004-06-09 | MERCK PATENT GmbH | Lateral flow test format for enzyme assays |
| US6703216B2 (en) | 2002-03-14 | 2004-03-09 | The Regents Of The University Of California | Methods, compositions and apparatuses for detection of gamma-hydroxybutyric acid (GHB) |
| CN100359008C (zh) * | 2003-09-05 | 2008-01-02 | 上海丰汇医学科技有限公司 | 酶法测定病人分析物浓度用的试剂 |
| ITMI20060629A1 (it) * | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| CN104458617A (zh) * | 2014-12-05 | 2015-03-25 | 重庆中元生物技术有限公司 | 一种α-羟丁酸脱氢酶检测试剂盒及其制备方法 |
| BR112021014997A2 (pt) * | 2019-01-31 | 2021-10-05 | F. Hoffmann-La Roche Ag | Kit de ensaio para determinar quantitativamente a concentração de amônia em uma amostra líquida aquosa, método para fornecer um kit de ensaio, uso de um kit de ensaio, kit de ensaio, mistura e dispositivo |
| WO2025211067A1 (ja) * | 2024-04-04 | 2025-10-09 | 株式会社シノテスト | 補酵素を含む測定試薬及びその安定化方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3413198A (en) * | 1966-06-30 | 1968-11-26 | Calbiochem | Reagents and method for assaying biological samples |
| US3776900A (en) * | 1971-04-26 | 1973-12-04 | Searle & Co | Stabilization of reduced coenzymes |
| FR2217296A1 (en) * | 1972-10-10 | 1974-09-06 | Inst Francais Du Petrole | Organic cpds. prepn. by co-enzymatic reduction - with continuous regeneration of the oxidised coenzyme with a reducing agent |
| AT339505B (de) * | 1974-03-14 | 1977-10-25 | Boehringer Mannheim Gmbh | Enzymatisches analysenverfahren |
| NL7603588A (nl) * | 1975-04-21 | 1976-10-25 | Hoffmann La Roche | Gestabiliseerde coenzymoplossing. |
| JPS5826320B2 (ja) * | 1975-12-27 | 1983-06-02 | 中外製薬株式会社 | ソクテイヨウシヤクソセイブツ |
| FR2344570A1 (fr) * | 1976-03-17 | 1977-10-14 | Modrovich Ivan | Procede de stabilisation d'un coenzyme labile |
| US4153511A (en) * | 1976-03-17 | 1979-05-08 | Modrovich Ivan Endre | Stabilized liquid coenzyme compositions |
| US4277562A (en) * | 1976-09-13 | 1981-07-07 | Modrovich Ivan Endre | Stabilized liquid enzyme and coenzyme compositions |
| JPS53107486A (en) * | 1977-02-28 | 1978-09-19 | Wako Pure Chem Ind Ltd | Stabilized nadh aqueous solution |
| US4189536A (en) * | 1977-11-09 | 1980-02-19 | Hycel, Inc. | Reagent systems, enzymatic assays and compositions therefor |
| DE2831580C2 (de) * | 1978-07-18 | 1980-09-18 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren und Reagens zur Bestimmung von Glycerin |
| CA1187388A (en) * | 1978-09-20 | 1985-05-21 | American Monitor Corporation | Stabilization of working reagent solutions containing nadh, nadph, and/or enzymes, and the use of such stabilized reagents in enzymes or substrate assays |
| US4218536A (en) * | 1978-10-03 | 1980-08-19 | Jonas Maurukas | Process-stable co-enzyme NAD solution |
| US4247633A (en) * | 1979-04-05 | 1981-01-27 | Pabst Brewing Company | Reagent for colorimetric determination of creative phosphokinase |
-
1980
- 1980-02-13 US US06/121,225 patent/US4394449A/en not_active Expired - Lifetime
- 1980-12-03 CA CA000366093A patent/CA1178875A/en not_active Expired
- 1980-12-08 EP EP80107733A patent/EP0034213B1/en not_active Expired
- 1980-12-08 AT AT80107733T patent/ATE10208T1/de not_active IP Right Cessation
- 1980-12-08 DE DE8080107733T patent/DE3069608D1/de not_active Expired
-
1981
- 1981-02-09 JP JP1703581A patent/JPS56124395A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| US4394449A (en) | 1983-07-19 |
| ATE10208T1 (de) | 1984-11-15 |
| EP0034213A1 (en) | 1981-08-26 |
| JPS56124395A (en) | 1981-09-30 |
| JPS6335238B2 (OSRAM) | 1988-07-14 |
| DE3069608D1 (en) | 1984-12-13 |
| EP0034213B1 (en) | 1984-11-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1178875A (en) | Stabilization of coenzymes in aqueous solution | |
| EP0973938B1 (en) | The use of nadph and nadh analogs in the measurement of enzyme activities and metabolites | |
| US4271264A (en) | Stabilized liquid enzyme and coenzyme compositions | |
| US4277562A (en) | Stabilized liquid enzyme and coenzyme compositions | |
| US4250254A (en) | Stabilized liquid enzyme and coenzyme compositions | |
| US4241179A (en) | Method for determining a transaminase in a biological fluid and reagent combination for use in the method | |
| EP0575610A1 (en) | HIGHLY SENSITIVE DETERMINATION OF AMMONIA, $g(alpha)-AMINO ACID OR $g(alpha)-KETO ACID AND COMPOSITION THEREFOR | |
| EP0468262B1 (en) | Reagents for CO 2 detection | |
| US5753453A (en) | Stable single liquid reagent for the determination of carbon dioxide in serum | |
| JPH0147999B2 (OSRAM) | ||
| CN114354524B (zh) | 一种稳定的液体检测试剂盒 | |
| US5506113A (en) | Measuring composition | |
| US5834227A (en) | Kit for assaying creatine kinase | |
| EP0721986A2 (en) | Creatine kinase reagent | |
| US7300769B2 (en) | Stabilized coenzyme solutions for determining dehydrogenase activity | |
| US4219645A (en) | Stabilized nicotinamide-adenine dinucleotides and process for their preparation | |
| JP5633669B2 (ja) | Ａｄｐの測定方法およびａｄｐ測定用キット | |
| CN113396226B (zh) | 氨检测测定中nadph或nadh的稳定化 | |
| KR102914921B1 (ko) | 암모니아 검출 분석에서의 nadph 또는 nadh의 안정화 | |
| CN1820071A (zh) | 酶法测定病人分析物浓度用的试剂 | |
| JPH08248028A (ja) | 生理活性物質測定用液状試薬 | |
| JP2001231596A (ja) | 検体の溶血による影響を回避する測定方法およびその方法に使用される測定試薬 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKEX | Expiry |